Plans have been submitted on behalf of Brookgate for a new 182,000 sq ft office in Cambridge.
Technology firm ARM has submitted plans for a 200,000 sq ft extension of its global headquarters in Cambridge
Gilead Sciences has launched a 90,000 sq ft requirement in Cambridge as it looks to double the space it occupies in the city
Legal & General, in partnership with Wrenbridge, is under offer to buy the Grafton Centre in Cambridge from M&G for around £100m – a 5.5% yield
Cambridge and Norwich have been reaping the benefits of a buoyant leisure market but Ipswich has struggled
IN DEPTH: Chinese investors are eyeing Cambridge opportunities as office yields in the city are expected to dip below 5% in the next 18 months
Will the big-money sale of one of the city’s shopping centres be the catalyst for overseas investment?
Now that the excitement surrounding the government’s £15bn road building programme has died down, is it full speed ahead?
Mayfair Capital Investment Management has upped its Property Income Trust for Charities portfolio to £350m after completing £17.3m of new purchases.
Cambridge city council has given AstraZeneca planning permission to build a £330m headquarters building on the outskirts of the city.
Hill has gained planning permission for a £60m development to deliver 208 zero-carbon homes in Cambridge.
The University of Cambridge has awarded contracts to two residential developers, Countryside and Hill, to deliver 400 homes in the first phase of the North West Cambridge development.